INTRODUCTION
A recent survey showed that 96% of Americans own a cellphone, of which 81% are “smart,” and that the number of smartphone owners is only projected to increase over time. Of smartphone users, 52% collect health information on their phones via one or more of the over 97,000 health and fitness applications (“health apps”) available for download. As health apps grow in sophistication, some are beginning to look and to function a great deal like health care. As a result, they raise issues core to health care, including safety, efficacy, and privacy. However, the laws and regulations designed to protect these key interests often do not apply to health apps. Instead, users of these apps may be left to rely on the law of consumer contracts. Drawing from bioethics, this Article asks if certain health app users deserve heightened protections when a consumer's legal duty to read the contract intersects with the ethics of informed medical decision-making.
A recent survey showed that 96% of Americans own a cellphone, of which 81% are “smart,”Footnote 1 and that the number of smartphone owners is only projected to increase over time.Footnote 2 Of smartphone users, 52% collect health information on their phonesFootnote 3 via one or more of the over 97,000 health and fitness applications (“health apps”) available for download.Footnote 4 As health apps grow in sophistication, some are beginning to look and to function a great deal like health care. As a result, they raise issues core to health care, including safety, efficacy, and privacy. However, the laws and regulations designed to protect these key interests often do not apply to health apps.Footnote 5 Instead, users of these apps may be left to rely on the law of consumer contracts. Drawing from bioethics, this Article asks if certain health app users deserve heightened protections when a consumer's legal duty to read the contract intersects with the ethics of informed medical decision-making.Footnote 6
Among the most illuminating health apps for this analysis are period and fertility trackers. These apps are designed to be data repositories of everything from basal body temperature to the consistency of cervical mucus, and advertise a variety of health insights, including fertility predictions. Users may rely on this information to make deeply personal choices about their health and reproduction. The liminal status of these apps at the boundary of consumer technology and health care makes them a perfect case study for how a contract law framework may be legally permissible but nevertheless, ethically problematic.
This Article proceeds in three parts. Part I introduces period and fertility trackers and the concerns raised by the misalignment of user expectations on crucial issues related to privacy and accuracy. Part II provides a brief introduction to the legal and regulatory environment of smartphone apps. In doing so, Part II exposes the shortcomings of these approaches for certain health apps, like period and fertility trackers. Finally, Part III looks to the ethical foundations of medical informed consent and extracts lessons for apps that are not quite health care and yet not entirely distinct. The borderline nature of these health apps, coupled with oversight designed for apps that are neatly categorized, can mean that some health apps are underregulated. We conclude that given the importance of privacy and accuracy in certain health apps, there are good reasons to rethink digital contracts in a manner that promotes informed decision-making.
I. SCHRÖDINGER'S APP
Health apps perform a variety of functions, enabling users to track, monitor, and act on physiological, psychological, or social health data.Footnote 7 Through creative use of embedded sensors, they can be used as fall detectors, spirometers, and heart rate sensors,Footnote 8 and can sync with wearable devices to gather additional data and provide customizable feedback.Footnote 9 Like “Schrödinger's cat,” which is “both living and dead … in equal parts,”Footnote 10 these apps exist in a liminal space that is not quite health care but not quite not. In this Part, we introduce period and fertility trackers as an example of a “Schrödinger's app.” We then explore accuracy and privacy and the unique harms that can result from a misalignment in user expectations and technological and legal realities.
A. Period and Fertility Trackers
One category of app that straddles the line between health care and everything else is period and fertility trackers. These apps allow users to record the dates of their menstrual cycles and associated symptoms, as well as other information about their gynecological health.Footnote 11 They can also be a convenient way to track biomarkers necessary for fertility-awareness-based methods of contraception—such as the consistency of cervical mucus or basal body temperature. Apps can then use this information to generate predictions about a user's fertility, which she, in turn, can use to make decisions that impact her health.Footnote 12 For example, a woman trying to conceive may use predictions about her most fertile days to time intercourse to maximize the possibility of conception.Footnote 13 Alternatively, these fertility prediction features may be used by women who seek to avoid conception, such as by planning to abstain from sex or to use barrier methods on fertile days.Footnote 14
While the use of smartphones in these contexts is relatively new, tracking periods as a form of contraception has been around for decades, gaining popularity in the 1930s (around the same time as Schrödinger was theorizing about cats).Footnote 15 Lately, there has been a resurgence of interest in fertility-awareness-based methods,Footnote 16 motivated by a range of considerations including the lack of side effects as compared to hormonal birth control, as well as concordance with specific religious directives.
One app, Natural Cycles, shows particular promise. It was also the first app to receive FDA clearance for marketing as contraception, paving the way for a “contraception software” category.Footnote 17 Research has shown that Natural Cycles is comparable to or better than other fertility-awareness-based methods when used as intended.Footnote 18 Another app, Dot, has also shown potential in early research to be as effective as other user-controlled, fertility-awareness-based methods.Footnote 19
The challenge is that nearly all apps on the market today—regardless of quality and how they are regulated—look like the Natural Cycles and Dot products. As a result, over 100 million women worldwide using free period-tracking appsFootnote 20 may assume that all apps are subject to the same standards, or that they all function in a substantially similar manner. This assumption is incorrect.Footnote 21
B. Accuracy and Privacy
Much like the traditional health care context, period-tracking apps raise serious concerns about both accuracy and privacy. As noted above, some women use period- and fertility-tracking apps to achieve or avoid conception. If the app inaccurately predicts fertile days, a couple may focus their sexual efforts on non- or less-fertile days, which may lessen the chances of conception as compared to random intercourse throughout the month.Footnote 22 If the app inaccurately predicts non-fertile days, a user trying to avoid conception may find herself pregnant.
Given the significance of the intended outcome—namely, avoiding or creating another human being—the accuracy of predictions is of critical importance. It is perhaps surprising then that very few available apps employ evidence-based methods of fertility awareness.Footnote 23 Furthermore, many of the available free period-tracking apps are inaccurate for the majority of women who do not have perfectly regular 28-day cycles.Footnote 24 Several studies examining the accuracy of period trackers have excluded currently available apps because they did not meet even threshold requirements for accuracy.Footnote 25 Consumers are not well-positioned to know if an app is providing accurate predictions about their health, and some women may never know they selected an inappropriate app until it is too late.
In addition to accuracy, the intimate nature of the information collected by these apps raises privacy concerns.Footnote 26 In fact, privacy is the very reason that some users track period- and fertility-related information in an app, as opposed to paper or digital calendars: they perceive apps to be more private than other methods.Footnote 27 This belief, however, may be erroneous in at least two respects: unintentional and intentional data sharing.
Period-tracking apps may be vulnerable to unintentional data sharing. For example, a 2016 Consumer Reports exposé outlined several privacy threats experienced by the app Glow.Footnote 28 Those vulnerabilities included: the ability of secondary users to link to other accounts without express permission from the primary user (permitting access to such intimate data as when the primary user last had intercourse and if she climaxed);Footnote 29 the transmission of personal data; and the ease of hacking and password change.Footnote 30 It concluded that it would be “easy for stalkers, online bullies, or identity thieves to use the information the app gathered to harm Glow's users.”Footnote 31 Additional privacy and security issues exist across these apps, including leaving sensitive user information and photos accessible to unauthorized individuals with even rudimentary hacking skills.Footnote 32
Intentional data sharing practices present further privacy concerns when data from the app is sold or otherwise provided to third parties. The profit-driven model of most apps significantly contributes to the tension between user privacy and data sharing in apps generally.Footnote 33 More complicated still, the primary companies setting the standards for privacy are also two of the most influential players in the mobile advertising business—namely, Google and Apple.Footnote 34 Some predict that in the absence of regulation, data mining for advertising and research will only intensify.Footnote 35
For period trackers specifically, the data collected by these apps is both sensitive and highly valuable to a variety of recipients. First, it represents a lucrative source of information for advertisers. Pregnancy and childbirth are key life stages during which individuals are actively seeking out new products and developing new brand loyalties.Footnote 36 Information generated by these apps can help inform targeted advertising. While the receipt of targeted advertising may seem benign, it can cause problems when advertisements reveal a pregnancy before a user intends to share the information. It may also cause emotional harm when advertisements persist after a miscarriage or an abortion.
Second, sharing this sensitive data facilitates research. One company, Flo, claims to have collected several billion data points and employs a team of 15 data scientists to sift the data for patterns to provide better predictions.Footnote 37 Some researchers are optimistic that the large datasets generated by these apps will help increase our understanding of fertility.Footnote 38 Other companies produce research with less compelling social value, including exploring links between menstruation and lunar cycles.Footnote 39 While a user may not perceive these uses as objectively harmful, advance knowledge of the use of one's data in research may be relevant to a user deciding between comparable apps.
Third, apps have expressed an interest in utilizing their datasets for insurance purposes as a means of enhancing risk assessments and creating “better” health insurance.Footnote 40 These apps are also attractive to companies offering wellness programs.Footnote 41 One app, Ovia, provides a version of its product that allows employers to receive anonymized data about their employees, including their sexual health and pregnancies.Footnote 42 Though these data are supposedly de-personalized or de-identified, research suggests that anyone with access to the information that users enter into these apps (e.g., employers, partners, insurers, or advertisers) may be able to identify users nonetheless.Footnote 43 This data sharing creates a risk of employment and insurance discrimination.Footnote 44
Finally, the intimate nature of the data provided may be of interest to more concerning recipients—both in the form of intentional and unintentional sharing. As noted above, information contained within an app may prove valuable to abusive partners or stalkers.Footnote 45 The data entered into these apps may also prove to be of interest to government actors, particularly by those opposed to abortion. For example, in states passing ever more stringent abortion laws, data entered into these apps may prove useful in criminal investigations about suspected abortions or suspicious miscarriages.Footnote 46 And while government interest in the date of last menstrual periods seems like a scene out of a dystopian novel, both the Trump Administration and the state of Missouri have already demonstrated a keen interest in tracking the menstrual cycles of women and young girls as part of efforts to limit abortion access.Footnote 47
II. UNDERREGULATION & THE RELIANCE ON CONSUMER CONTRACTS
Though Schrödinger's Apps can look and act like health care, they are regulated as though they are not. Put simply, users of these personal health technologies generally do not receive the same protections as patients. This Part gives a brief overview of the current regulatory oversight of health apps and how many of the protections we enjoy in a health care context are inapplicable to the vast majority of health apps. It then turns to the law of consumer contracts and the importance of terms of service and privacy policies. It concludes by considering the shortcomings of these frameworks and how our current approaches inadequately protect health app consumers.
A. Traditional Regulatory Regimes
Heath care is one of the most heavily regulated industries. However, those same regulations generally do not extend to health apps. In some cases, protections recognizable in health care will apply in limited circumstances. For the rest, other types of consumer protections partially fill the gap.
1. Health Regulation
In a typical health care context, patients can—with some limitations—rely on U.S. Food and Drug Administration (“FDA”) approval for some guarantee of safety and efficacy and the Health Insurance Portability and Accountability Act (“HIPAA”) privacy and security rule to ensure appropriate handling of protected health information. While sometimes these protections apply to health apps,Footnote 48 the vast majority of health apps fall outside the scope of these laws and regulations.
For example, the FDA only regulates an app as a medical device if it is intended to diagnose, cure, mitigate, or prevent disease or other conditions.Footnote 49 The 21st Century Cures Act expressly excludes from regulation devices “for maintaining or encouraging a healthy lifestyle” that are “unrelated to the diagnosis, cure, mitigation, prevention, or treatment of a disease or condition.”Footnote 50 Most health apps fall within this carve-out.Footnote 51 The lack of formal regulation or approval processes for the vast majority of period-tracking apps creates considerable variation in the “medical soundness” of the apps entering the market.Footnote 52
Similarly, HIPAA applies only in limited circumstances, such as when the app is “creat[ing], receiv[ing], maintain[ing], or transmit[ting] protected health information on behalf of a covered entity or another business associate.”Footnote 53 Notably, HIPAA does not apply if the health app vendor is not a covered entity or does not employ a business model that involves acting as a business associate.Footnote 54
The general lack of regulation or a sound evidentiary basis underlying these apps is cause for concern, as is the way they handle and transmit user data.Footnote 55 Consequently, the underregulation of health and wellness apps has not gone unnoticed by the academic community. Some scholars have called for minimum standards of disclosure for health apps, including a notification requirement about who will access data, the type of collected data, and how it will be used and stored.Footnote 56 Others have argued for more extensive FDA regulation of health and wellness apps.Footnote 57 However, until policymakers reach a consensus about whether and how to close these gaps, consumers remain without many of the protections often expected in a health context.
2. Industry Regulations
To say an app user is not entitled to informed consent, or an app does not fall under the purview of the FDA or HIPAA, does not mean that no rules apply. At the industry level, developers must comply with rules for posting to the Google Play Android Apps StoreFootnote 58 or the Apple App Store.Footnote 59 State laws and guidelines may also apply, such as state consumer protection laws or nonbinding recommendations from State Attorneys General.Footnote 60
Perhaps the most dominant player in this space—at least as far as the United States is concernedFootnote 61—is the Federal Trade Commission (“FTC”). The FTC has brought lawsuits against apps for making false or misleading claims, such as purporting to replace traditional blood pressure monitorsFootnote 62 or to treat acne.Footnote 63 Notably, the issue with these apps was not with the apps themselves but the statements made about their capabilities. In other words, the FTC does not address issues related to accuracy and privacy so long as the developer does not make false or misleading statements.
Nevertheless, these alternative mechanisms have several shortcomings. First, while industry standards exist, companies that benefit financially from advertising revenue associated with app use have little incentive to set a high bar for posting to their respective app stores. Second, state-specific protections do not apply to all users—only those in specific states—nor does it apply to all apps. Third, the FTC's approaches are underenforced and reactive, meaning that users may face various and possibly substantial harms before any meaningful oversight occurs. Fourth is the issue of bandwidth. The steady stream of innovation makes it difficult to monitor the claims and practices of every app. Relatively few users may download some apps, further disincentivizing the resource expenditure required for investigation and enforcement.
B. Consumer Contracts
Buyer beware: what a consumer believes ought to be true about health app accuracy and data privacy is not always the reality. In general, there are no assurances beyond those contained in the terms of service and in privacy policies. For health app users, the law of consumer contracts may provide the most—and, in some cases, the only—protection.
1. Terms of Service and Privacy Policies
For the vast majority of health apps, consumers may be limited to the recourses available in contract law. To use an app, a user must agree to the terms of service and privacy policies, often presented via a click- or browse-wrap contract.Footnote 64 In general, these contracts are presumed enforceable so long as the terms are not deceptive or intolerable as determined by the courts.Footnote 65
These types of contracts are common in technology. They also differ from the historical model of contracts in several key ways. First, unlike traditional contracts, there is no negotiation involved in their formation.Footnote 66 Instead, the terms of service and privacy policies serve an informative function for users. For example, these documents include disclaimers of liability, specifications of relevant jurisdiction, arbitration provisions, or warranties. Second, most terms of service contain clauses that allow for unilateral amendments.Footnote 67 In some cases, this language will also specify if or how an app will notify users of the change. When an app does not affirmatively inform users, the language often explains that it is the user's responsibility to periodically check back to review the terms of service and privacy policies. In most cases, continued use of the app is considered acceptance of new contract terms.Footnote 68 Third, these contracts acknowledge that there is no negotiation or mutual assent, but assume that the user is acting autonomously in selecting one app over another.
Given that companies set terms without negotiation and can amend those terms at any time, making an informed decision to initiate or continue app use would seem to require that users read and understand app terms of service and privacy policies. Yet, as has been well-documented by the empirical literature, terms of service and privacy policies in apps are unread by users and further, often difficult to understand.Footnote 69 Nevertheless, the law does not usually distinguish whether a user ever reads the content of the terms of service or privacy policies. Contract law assumes a party to a contract is capable of acting autonomously, whether she knows what she is agreeing to or not.Footnote 70 This assumption means a consumer can legally bind herself in a contract without even knowing it, without ever clicking an “I agree” button, and without ever accessing the terms of the agreement.Footnote 71
Several commentators have raised serious and valid concerns about the appropriateness of click- or browse-wrap contracts, especially in light of the reality that they are often unread.Footnote 72 These concerns take on increased urgency when apps involve highly personal data, such as those involving intimate health information. Yet, these apps are not afforded the formal protections given to health information in traditional medical contexts or within certain types of health apps, such as those that either communicate with a covered entity or qualify as a medical device. For this subset of in-between apps, ignorance of the terms of service and privacy policies may create more serious problems.
2. Shortcomings
As noted above, forming binding contracts through terms of service and privacy policies is standard practice in consumer transactions. However, even if these documents contain relevant information about the accuracy and privacy of data, it is unlikely that a user can find them, will read them, or be able to understand them if she does.Footnote 73 Moreover, companies can unilaterally change their terms with discretion regarding if or how to notify users.Footnote 74 Yet because they look and act like health care, period and fertility tracking apps reveal that the presentation and content of material information and assumptions about user autonomy create a misalignment in user expectations, which can result in real-world harm.
When it comes to efficacy and reliability, the terms of service may be the most accurate source of medical and liability disclaimers, even as marketing materials and in-app graphics suggest a different reality. For example, one period-tracking app advertises using medical images and language, indicating that it can send real-time alerts that symptoms might be a sign of something dangerous.Footnote 75 This same app simultaneously includes language in the terms of service that the app is not intended to give medical advice.Footnote 76 It is also common for apps to claim expertise and legitimacy by referencing science and medicine.Footnote 77 Some of these companies even have “chief medical officers,” and at least one app cites development by such esteemed contributors as “Harvard scientists, pregnancy specialists, and fit moms.”Footnote 78 Meanwhile, the terms will indicate that the app is not intended for use as medical advice, is provided “as is,” makes no warranties, and the company is free of liability.Footnote 79 Given the contradictions in these messages, a consumer's confusion about whether she can rely on the health information generated by her app is understandable. Further, by gesturing at the general idea of health and medicine without explicitly stating it can cure, treat, or diagnose, these apps avoid FTC enforcement.Footnote 80
Information about privacy may not be subject to the same onslaught of inconsistent marketing, but it suffers from similar challenges with readability and accessibility.Footnote 81 The fact that users do not view privacy policies can create problems given that these documents are often the sole, (generally) accurateFootnote 82 sources of information about intentional data sharing.Footnote 83 At times, these convoluted privacy policies contain shocking terms. For example, some apps that provide phone numbers and enable in-app calling will use these documents as the place to warn that they may record calls placed by users from within the apps.Footnote 84
When it comes to health apps like period trackers, relying on terms of service and privacy policies to deliver critical information about accuracy and privacy is insufficient. These documents are not designed to facilitate users' understanding of the relevant terms—and may, in fact, be intended to frustrate their understanding.Footnote 85 The issue is similar to the tension the court in Canterbury v. Spence, a landmark medical informed consent case, observed in 1972: “[c]aveat emptor is not the norm for the consumer of medical services.”Footnote 86 For these and other Schrödinger's apps, the way we protect patients may provide valuable lessons for how we ought to protect consumers.
III. LESSONS FROM INFORMED CONSENT
As explored in Part II, our current legal and regulatory frameworks do not adequately protect users of health apps that perform functions that increasingly emulate health care services. Period and fertility trackers clearly illustrate these shortcomings. In seeking answers to questions about how to improve these protections, Part III looks to the ethical underpinnings of medical informed consent.
A. The Ethics of Informed Consent
From a legal standpoint, period tracking apps do not create a physician-patient relationship and do not provide medical treatment. At the same time, these health technologies purport to generate reliable health-related recommendations and a suggested course of action with significant health implications. Thus, while apps cannot be said to have fiduciary duties to their users, nevertheless, there are strong moral arguments for facilitating informed decision-making about their use. Lessons from the paradigm of informed consent can therefore inform how we might reconsider the presentation and content of terms of service and privacy policies.
From an ethical perspective, informed consent centers on autonomous choice.Footnote 87 At least four reasons support the requirement of informed consent: (1) individuals are best positioned to know their interests, (2) information increases the likelihood that an intervention will be beneficial due to appropriate expectations, (3) there is social value in allowing individual decision-making, and (4) individuals have a right to control what happens to their bodies.Footnote 88 The right to fully autonomous choice is not absolute, but restricting autonomy requires justification based on other moral principles.Footnote 89
In ideal circumstances, effective informed consent processes help ensure that patients are aware of their situation, know what to expect from their treatment choices, can weigh the costs and benefits of those decisions, and do so in light of their own preferences and values. Moreover, it places the patient at the center of their own health care, ideally preventing paternalistic decision-making.
To argue for the importance of informed consent is not to hold that informed consent is required before every health care decision. Some circumstances allow health care providers to obtain simple consent instead.Footnote 90 For example, when treating a patient with contact dermatitis resulting from a ring containing nickel, it is not necessary for a clinician to engage her patient in an extensive discussion about the risks or benefits of topical corticosteroid use.Footnote 91 In such low-risk situations, simple consent is appropriate, involving: a brief explanation of the issue, instructions about the medication, and asking if the patient has any questions. However, informed consent is necessary in decisions involving higher risk, in order to educate a patient about the benefits and risks of different options, and when multiple medically-appropriate options exist, to facilitate decisions that reflect the patient's own values and preferences.
B. Application to Period and Fertility Trackers
The digital world creates new challenges for informed consent.Footnote 92 As with other consumer-oriented applications marketed as “wellness” tools, informed consent is completely absent in most period- and fertility-tracking apps.Footnote 93 Prior research suggests that terms of service and privacy policies likely obscure information that would be relevant to make a decision consistent with one's values and preferences.Footnote 94 However, even if a user opted to review these in detail, developers do not write terms of services and privacy policies at a reading level conducive to informed consent. Higher reading levels impede readability, and in turn, prevent users from fully understanding the risks associated with using an app.Footnote 95 Our prior research has shown that it would take years of post-secondary education to fully understand terms of service and privacy policies—and that is only if you can find them in the first place.Footnote 96
Ethical considerations of informed consent likely apply to all health apps but may be particularly relevant for period- and fertility-tracking apps, given the nature and magnitude of the health consequences associated with their use. One broad challenge in obtaining informed consent is determining who has decision-making authority in a given context. In the context of reproductive decision-making, experts agree that the choice of a birth control method belongs to the patient.Footnote 97 As an initial matter, this makes our analysis simple: women have the right to autonomous choice concerning birth control, including in the form of digitally-assisted fertility-awareness methods facilitated by the use of period-tracking apps. Given that at least some users utilize these apps for contraceptive purposes, the current presentation of accuracy and privacy information is ethically problematic for at least two reasons.
First, respect for autonomy is foundational to medical informed consent. We argue that terms of service and privacy policies do not respect user autonomy. Deceit is widely recognized as violating the informed consent requirement.Footnote 98 While this certainly includes outright lies, it also includes deception that intentionally creates a false impression without explicitly lying.Footnote 99 Various aspects of current terms of service and privacy policies for period-tracker apps arguably constitute such non-lying deception, including manipulative under-disclosure of pertinent information related to accuracy and privacy.
Second, years of research have demonstrated that a consumer is unlikely to access, read, or re-visit terms of service.Footnote 100 Because an app owner or developer would seek to restrict autonomous choice by obscuring important information, the burden of moral proof is on the company to justify the infringement.Footnote 101 The reasons for presenting information in this format is precisely because users are unlikely to read or access it, creating a favorable environment to sneak in “crook” provisions.Footnote 102 Apps are, in a Kantian sense, treating an autonomous person as merely a means to an end (data collection and vending) and not an end in herself.Footnote 103 Those practices may be legal, but they are not ethical.
Instead, apps should present material terms to users in a manner that encourages comprehension and affirmative consent. At a minimum, this must include information about how the app calculates predictions about the user's menstrual cycle, the app's capabilities for use as contraception, and disclaimers that information generated by the app is not medical advice. Providing sufficient, unbiased information is crucial in situations that present serious risks and ambiguous evidence—such as those involving conception or actions to prevent it.Footnote 104 When we empower individuals with more information about the benefits, risks, and limitations of health apps, they are in a better position to make decisions about whether the app is appropriate for their intended use.Footnote 105
Additionally, terms of service and privacy policies often contain unilateral amendment provisions. Ethically speaking, if there is a unilateral amendment to a consumer contract, the app should seek to notify the user in a manner that allows them to meaningfully consent to the change or make the decision to find a different app. Apps should not assume that users will independently obtain all information necessary to make an informed choice by reading the terms of service and privacy policies and periodically revisiting them to ensure her understanding is up-to-date.
Finally, consumer contracts and the ethical foundation of informed consent contain different assumptions about autonomy. In contract law, we simply assume parties can form and enter into contracts—that is, they are presumed at baseline to be acting autonomously. In an informed consent context, by contrast, steps are affirmatively taken to preserve and maximize autonomy by ensuring that individuals have the information they need to make informed choices, in recognition of the inherent informational asymmetry between clinicians and patients that exists at baseline. Health apps, like period trackers, would benefit from drafting their terms of service and privacy policies with a similar perspective in mind. By empowering users with accessible and understandable information necessary to make informed choices about app use, health apps can enhance user autonomy and support genuinely informed decisions.
Careful consideration of the ethical underpinnings and not solely the legal practicalities of informed consent is crucial. This is not to say, however, that the appropriate remedy is to merely replicate the process of medical informed consent in a health app context, as doing so may only serve to stifle innovation and create an annoying deluge of digital documents that consumers—especially Americans unaccustomed to extensive consent requirements in a digital context—do not want to read. Moreover, the informed consent process is subject to many justifiable criticisms.Footnote 106 Scholars like Jorge Contreras have likened the issues with contemporary informed consent processes to the problems with long and complicated clickwrap agreements that are standard in computer software.Footnote 107 The wholesale transfer of medical informed consent to the app context may be impracticable, and even if it is practicable, may exacerbate some existing problems. However, by examining the ethical considerations underlying informed consent and how they apply to Schrödinger's apps, we may inch closer to a policy solution.
CONCLUSION
Critical consideration of the disconnect between contract law, the norms of the technology industry, and the ethical considerations underlying health care become increasingly important in light of the growing market for consumer health technology. While there are many arguments for and against increased federal oversight of health apps, it is clear that our scant regulatory oversight and current reliance on consumer contracts are insufficient. As a result, lessons from health care and the ethical foundations of those lessons will take on new importance as we continue to debate the role of law and policy in consumer health technology.
Informed consent tells us that individuals need a certain amount of information presented in an accessible manner to make choices. These lessons suggest that apps should highlight certain material information outside the confines of terms of service and privacy policies, especially in contexts in which the consequences to health can be significant and the protection provided by contract law can be lacking. By modifying this approach and ensuring meaningful re-consent in the event of a unilateral amendment, health apps can enhance user autonomy. These changes are ethically desirable.
More research is necessary, however, to determine when and how to implement these improvements. Future disclosure requirements intended to enhance informed choice, while perhaps not quite quantum theory, may nevertheless prove to be anything but straightforward. Though Schrödinger's apps may suffer from challenges in clear categorization, they can also benefit from their not-quite-health-care and not-quite-not state by borrowing the best practices from each.
The authors wish to thank Jessica L. Roberts, Jim Hawkins, Emily Largent, and the participants of the 2020 American Journal of Law & Medicine Annual Symposium, especially Rebecca Mashni and the editors at the American Journal of Law & Medicine. They also appreciate and wish to acknowledge the administrative support of Elaine Fiala.
